Ian T Clark's Net Worth
$22.9 Million
Who is Ian T Clark?
Ian T Clark has an estimated net worth of $22.9 Million. This is based on reported shares across multiple companies, which include AGIOS PHARMACEUTICALS, INC., Guardant Health, Inc., Corvus Pharmaceuticals, Inc., AVROBIO, Inc., Kite Pharma, Inc., Olema Pharmaceuticals, Inc., Forty Seven, Inc., TerraVia Holdings, Inc., DENDREON CORP, GENENTECH INC, Kyverna Therapeutics, Inc., and GoodRx Holdings, Inc..
SEC CIK
Ian T Clark's CIK is 0001336504
Past Insider Trading and Trends
2008 was Ian T Clark's most active year for acquiring shares with 75 total transactions. Ian T Clark's most active month to acquire stocks was the month of June. 2008 was Ian T Clark's most active year for disposing of shares, totalling 152 transactions. Ian T Clark's most active month to dispose stocks was the month of June. 2008 saw Ian T Clark paying a total of $5,112,366.97 for 108,771 shares, this is the most they've acquired in one year. In 2019 Ian T Clark cashed out on 217,666 shares for a total of $8,145,702.82, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AGIOS PHARMACEUTICALS, INC. (AGIO) Snapshot price: $43.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +31.93% | 1.58K |
—
|
—
| 6.55K |
May 20
| |||
Form 4
| +51.43% | 1.69K |
—
|
—
| 4.96K |
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| +134.14% | 1.88K |
—
|
—
| 3.28K |
May 28 - May 29
| |||
Form 4
|
∞
| 1.4K |
—
|
—
| 1.4K |
May 29 - May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Guardant Health, Inc. (GH) Snapshot price: $24
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +76.13% | 6.78K |
—
|
—
| 15.68K |
Jun 12
| |||
Form 4
| +304.96% | 6.7K |
—
|
—
| 8.9K |
Jun 14
| |||
Form 4
|
∞
| 2.2K |
—
|
—
| 2.2K |
Jun 15
| |||
Form 4
|
—
|
0
|
$67.09 | -$135,382.32 |
0
|
Scheduled
|
Sep 1
| ||
Form 4
| -100.00% | -4.64K |
$96.92 | -$995,056.72 |
0
|
Scheduled
|
Jun 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
$82.05 | -$83,788.12 | 4.64K |
Scheduled
|
Apr 26
| ||
Form 4
|
—
|
0
|
$68.14 | -$68,815.58 | 4.64K |
Scheduled
|
Mar 25
| ||
Form 4
|
—
|
0
|
$79.09 | -$80,603.16 | 4.64K |
Scheduled
|
Feb 25
| ||
Form 4
|
—
|
0
|
$83.09 | -$84,907.16 | 4.64K |
Scheduled
|
Jan 25
| ||
Form 4
|
—
|
0
|
$66.71 | -$336,384.50 | 4.64K |
Scheduled
|
Jan 4
| ||
Form 4
|
—
|
0
|
$69.59 | -$70,381.16 | 4.64K |
Scheduled
|
Dec 28
| ||
Form 4
|
—
|
0
|
$62.09 | -$311,555.80 | 4.64K |
Scheduled
|
Dec 3
| ||
Form 4
|
—
|
0
|
$58.73 | -$58,695.80 | 4.64K |
Scheduled
|
Nov 25
| ||
Form 4
|
—
|
0
|
$54.73 | -$271,959.00 | 4.64K |
Scheduled
|
Nov 3
| ||
Form 4
|
—
|
0
|
$54.11 | -$53,719.30 | 4.64K |
Scheduled
|
Oct 26
| ||
Form 4
|
—
|
0
|
$56.15 | -$335,529.08 | 4.64K |
Scheduled
|
Sep 25 - Oct 5
| ||
Form 4
|
—
|
0
|
$46.72 | -$778,016.46 | 4.64K |
Scheduled
|
Sep 8
| ||
Form 4
|
—
|
0
|
$42.72 | -$41,474.42 | 4.64K |
Scheduled
|
Jun 25
| ||
Form 4
| +256.61% | 3.34K |
—
|
—
| 4.64K |
Jun 12
| |||
Form 4
|
—
|
0
|
$45.85 | -$224,184.60 | 1.3K |
Scheduled
|
Jun 3
| ||
Form 4
|
—
|
0
|
$51.34 | -$50,744.16 | 1.3K |
Scheduled
|
May 26
| ||
Form 4
|
—
|
0
|
$38.17 | -$182,893.10 | 1.3K |
Scheduled
|
May 4
| ||
Form 4
|
—
|
0
|
$40.84 | -$39,446.16 | 1.3K |
Scheduled
|
Apr 27
| ||
Form 4
|
—
|
0
|
$37.09 | -$176,989.98 | 1.3K |
Scheduled
|
Apr 14
| ||
Form 4
|
—
|
0
|
$37.09 | -$35,411.16 | 1.3K |
Scheduled
|
Mar 25
| ||
Form 4
|
—
|
0
|
$41.26 | -$199,463.50 | 1.3K |
Scheduled
|
Mar 3
| ||
Form 4
|
—
|
0
|
$42.09 | -$40,791.16 | 1.3K |
Scheduled
|
Feb 25
| ||
Form 4
|
—
|
0
|
$40.21 | -$193,814.50 | 1.3K |
Scheduled
|
Feb 3
| ||
Form 4
|
—
|
0
|
$40.75 | -$39,343.94 | 1.3K |
Scheduled
|
Jan 27
| ||
Form 4
|
—
|
0
|
$41.03 | -$198,226.10 | 1.3K |
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
$43.44 | -$42,238.38 | 1.3K |
Scheduled
|
Dec 26
| ||
Form 4
|
—
|
0
|
$38.48 | -$184,534.00 | 1.3K |
Scheduled
|
Dec 3
| ||
Form 4
|
—
|
0
|
$41.18 | -$39,806.62 | 1.3K |
Scheduled
|
Nov 25
| ||
Form 4
|
—
|
0
|
$38.00 | -$181,951.60 | 1.3K |
Scheduled
|
Nov 4
| ||
Form 4
|
—
|
0
|
$37.09 | -$212,466.96 | 1.3K |
Scheduled
|
Oct 28
| ||
Form 4
|
—
|
0
|
$38.09 | -$36,487.16 | 1.3K |
Scheduled
|
Sep 25
| ||
Form 4
|
—
|
0
|
$44.94 | -$219,288.80 | 1.3K |
Scheduled
|
Sep 3
| ||
Form 4
|
—
|
0
|
$49.11 | -$48,350.06 | 1.3K |
Scheduled
|
Aug 26
| ||
Form 4
|
—
|
0
|
$46.97 | -$828,605.42 | 1.3K |
Scheduled
|
Aug 6
| ||
Form 4
|
∞
| 1.3K |
—
|
—
| 1.3K |
Jun 18
| |||
Form 4
|
—
|
0
|
$35.05 | -$166,053.70 |
0
|
Scheduled
|
May 3
| ||
Form 4
|
—
|
0
|
$34.64 | -$32,780.34 |
0
|
Scheduled
|
Apr 25
| ||
Form 4
|
—
|
0
|
$39.04 | -$5,701,143.84 | 81.72K |
Scheduled
|
Apr 15
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Corvus Pharmaceuticals, Inc. (CRVS) Snapshot price: $3.96
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVROBIO, Inc. (AVRO) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kite Pharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.10K |
$180.00 |
—
|
0
|
Oct 3
| |||
Form 4
| +51.39% | 2.41K |
—
|
—
| 7.1K |
Jun 20
| |||
Form 4
|
∞
| 4.69K |
—
|
—
| 4.69K |
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||